SG11202011638WA - Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof - Google Patents
Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereofInfo
- Publication number
- SG11202011638WA SG11202011638WA SG11202011638WA SG11202011638WA SG11202011638WA SG 11202011638W A SG11202011638W A SG 11202011638WA SG 11202011638W A SG11202011638W A SG 11202011638WA SG 11202011638W A SG11202011638W A SG 11202011638WA SG 11202011638W A SG11202011638W A SG 11202011638WA
- Authority
- SG
- Singapore
- Prior art keywords
- fused
- preparation
- pharmaceutical composition
- method therefor
- formamide compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810491115.3A CN110511218A (zh) | 2018-05-21 | 2018-05-21 | 一类并环吡唑啉酮甲酰胺类化合物及其制备方法、药物组合物和用途 |
| PCT/CN2019/087867 WO2019223704A1 (zh) | 2018-05-21 | 2019-05-21 | 一类并环吡唑啉酮甲酰胺类化合物及其制备方法、药物组合物和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011638WA true SG11202011638WA (en) | 2020-12-30 |
Family
ID=68615979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011638WA SG11202011638WA (en) | 2018-05-21 | 2019-05-21 | Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210221807A1 (pt) |
| EP (1) | EP3798218A4 (pt) |
| JP (1) | JP7339282B2 (pt) |
| KR (1) | KR102658011B1 (pt) |
| CN (2) | CN110511218A (pt) |
| AU (1) | AU2019273337B2 (pt) |
| BR (1) | BR112020023870A2 (pt) |
| CA (1) | CA3101223A1 (pt) |
| EA (1) | EA202092766A1 (pt) |
| SG (1) | SG11202011638WA (pt) |
| WO (1) | WO2019223704A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20180094A1 (ar) | 2017-10-18 | 2019-04-18 | Hk Inno N Corp | مركب حلقي غير متجانس كمثبط بروتين كيناز |
| WO2021233236A1 (zh) * | 2020-05-18 | 2021-11-25 | 北京范恩柯尔生物科技有限公司 | 取代的杂芳基化合物及其组合物和用途 |
| CN113912628B (zh) * | 2020-07-10 | 2023-05-02 | 北京范恩柯尔生物科技有限公司 | 三嗪类化合物及其组合物和用途 |
| TW202413367A (zh) * | 2022-08-19 | 2024-04-01 | 財團法人國家衛生研究院 | Ｔａｍ受體抑制劑 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| EP2349328A1 (en) | 2008-10-01 | 2011-08-03 | Ludwig Institute For Cancer Research | Methods for the treatment of cancer |
| KR100961410B1 (ko) * | 2008-10-14 | 2010-06-09 | (주)네오팜 | 단백질 키나제 억제제로서 헤테로사이클릭 화합물 |
| CN102086211B (zh) * | 2009-12-08 | 2013-09-11 | 广东东阳光药业有限公司 | 作为蛋白激酶抑制剂的芳杂环化合物 |
| AU2012339640B2 (en) * | 2011-11-14 | 2017-01-05 | Ignyta, Inc. | Uracil derivatives as AXL and c-MET kinase inhibitors |
| CN104974162B (zh) * | 2014-04-09 | 2018-09-14 | 广东东阳光药业有限公司 | 双环吡唑酮化合物及其使用方法和用途 |
| WO2016104617A1 (ja) | 2014-12-25 | 2016-06-30 | 小野薬品工業株式会社 | キノリン誘導体 |
-
2018
- 2018-05-21 CN CN201810491115.3A patent/CN110511218A/zh active Pending
-
2019
- 2019-05-21 AU AU2019273337A patent/AU2019273337B2/en active Active
- 2019-05-21 EA EA202092766A patent/EA202092766A1/ru unknown
- 2019-05-21 CN CN201980034774.7A patent/CN112236430B/zh active Active
- 2019-05-21 SG SG11202011638WA patent/SG11202011638WA/en unknown
- 2019-05-21 EP EP19806732.4A patent/EP3798218A4/en active Pending
- 2019-05-21 US US17/057,199 patent/US20210221807A1/en active Pending
- 2019-05-21 CA CA3101223A patent/CA3101223A1/en active Pending
- 2019-05-21 WO PCT/CN2019/087867 patent/WO2019223704A1/zh unknown
- 2019-05-21 KR KR1020207036703A patent/KR102658011B1/ko active IP Right Grant
- 2019-05-21 JP JP2020565414A patent/JP7339282B2/ja active Active
- 2019-05-21 BR BR112020023870-8A patent/BR112020023870A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102658011B1 (ko) | 2024-04-17 |
| CA3101223A1 (en) | 2019-11-28 |
| JP7339282B2 (ja) | 2023-09-05 |
| KR20210011988A (ko) | 2021-02-02 |
| US20210221807A1 (en) | 2021-07-22 |
| AU2019273337B2 (en) | 2022-02-17 |
| CN112236430A (zh) | 2021-01-15 |
| EP3798218A1 (en) | 2021-03-31 |
| JP2021524471A (ja) | 2021-09-13 |
| EP3798218A4 (en) | 2022-03-02 |
| BR112020023870A2 (pt) | 2021-02-09 |
| WO2019223704A1 (zh) | 2019-11-28 |
| CN110511218A (zh) | 2019-11-29 |
| CN112236430B (zh) | 2023-02-17 |
| AU2019273337A1 (en) | 2021-01-21 |
| EA202092766A1 (ru) | 2021-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
| ZA202001447B (en) | M-diamide compound and preparation method therefor and use thereof | |
| IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
| EP3539963A4 (en) | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | |
| SG11202106706TA (en) | Heterocyclic compound intermediate, preparation method therefor and application thereof | |
| EP3835296A4 (en) | KETOAMIDE COMPOUND AND METHOD FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| LT3453707T (lt) | Benzazepino darinys, gamybos būdas, farmacinė kompozicija ir jos naudojimas | |
| HUE049952T2 (hu) | Pirazolon vegyület vagy sója, elõállítási eljárása, herbicid hatású készítménye és alkalmazása | |
| EP3424928A4 (en) | HETEROCYCLIC NITROGEN COMPOUND, PREPARATION METHOD, INTERMEDIATE, COMPOSITION AND USE | |
| PT3580208T (pt) | Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro | |
| SG11202011638WA (en) | Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof | |
| IL272446A (en) | Penta-condensed hexa-heterocyclic compounds, method for their preparation, drug combination and use thereof | |
| GB201904104D0 (en) | Composition, method and use | |
| EP3715342A4 (en) | COMPONENT CONTAINING FLUOROSULFONYL, INTERMEDIATE THEREOF, RELATED PREPARATION PROCESS AND CORRESPONDING USE | |
| EP3556761A4 (en) | PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PRODUCTION METHOD THEREFOR, AND MEDICAL USE THEREOF | |
| IL285378A (en) | A heterocyclic compound, a medical preparation containing it, a method for its preparation, and its use | |
| EP3789384A4 (en) | FORMAMIDE COMPOUND, PROCESS FOR PREPARATION AND USE | |
| SG11202008531RA (en) | Oxazino-quinazoline and Oxazino-quinoline Type Compound, Preparation Method and Uses Thereof | |
| EP3686197A4 (en) | 2-SUBSTITUTED PYRAZOLAMINO-4-SUBSTITUTED AMINO-5-PYRIMIDINE FORMAMIDE COMPOUND, COMPOSITION AND ITS USE | |
| IL282817A (en) | New material, production method, and its use | |
| EP3872065C0 (en) | SULFOBIPHENYL COMPOUND, ITS PREPARATION PROCESS AND ITS APPLICATIONS | |
| EP3741759A4 (en) | HETEROCYCLIC COMPOUND, ITS PREPARATION PROCESS AND ITS USE IN MEDICINE | |
| PL3750893T3 (pl) | Związek dioksazoliny, sposób jego wytwarzania oraz jego zastosowania | |
| EP3564215A4 (en) | POLYHYDROXYPHTHALAZINONE COMPOUND, PRODUCTION METHOD THEREFOR AND USE THEREOF | |
| IL276410A (en) | Pyrazole compounds and their preparation |